Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Nanoparticle-based immunomagnetic assay of plasma biomarkers for differentiating dementia and prodromal states of Alzheimer's disease - A cross-validation study 2020-03-25
  2. Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study 2019-01-01
  3. Prodromal cognitive disorder in Alzheimer's disease 1999-07-01

Studies

3 studies carry this tag.

Date range

1999 to 2020

Top journals

  • International journal of geriatric psychiatry 1
  • Journal of Alzheimer's disease : JAD 1
  • Nanomedicine : nanotechnology, biology, and medicine 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Nanoparticle-based immunomagnetic assay of plasma biomarkers for differentiating dementia and prodromal states of Alzheimer's disease - A cross-validation study

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Nanomedicine : nanotechnology, biology, and medicine 2020-03-25 Biomarkers

    Blood-based biomarker assays of plasma β-amyloid (Aβ) and tau have the advantages of cost-effective and less invasive for the diagnosis of Alzheimer's disease (AD).

  2. Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Journal of Alzheimer's disease : JAD 2019-01-01 Biomarkers

    It is an open issue whether blood biomarkers serve to diagnose Alzheimer's disease (AD) or monitor its progression over time from prodromal stages.

  3. Prodromal cognitive disorder in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. International journal of geriatric psychiatry 1999-07-01 Cognitive tests and assessment

    Patterns of cognitive impairment may be detected in cases of AD 2 years before formal clinical diagnosis, although high education level prolongs competence, principally on verbal tasks.

All topic tags with their study counts